Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 282

1.

Acquired dysfibrinogenemia caused by monoclonal production of immunoglobulin lambda light chain.

Dear A, Brennan SO, Sheat MJ, Faed JM, George PM.

Haematologica. 2007 Nov;92(11):e111-7.

PMID:
18024387
[PubMed - indexed for MEDLINE]
Free Article
2.

Acquired dysfibrinogenemia secondary to multiple myeloma.

Kotlín R, Sobotková A, Riedel T, Salaj P, Suttnar J, Reicheltová Z, Májek P, Khaznadar T, Dyr JE.

Acta Haematol. 2008;120(2):75-81. doi: 10.1159/000160182. Epub 2008 Oct 8.

PMID:
18841003
[PubMed - indexed for MEDLINE]
3.

Crystal-storing histiocytosis and crystalline keratopathy caused by monoclonal gammopathy of undetermined significance.

de Alba Campomanes AG, Rutar T, Crawford JB, Seiff S, Goodman D, Grenert J.

Cornea. 2009 Oct;28(9):1081-4. doi: 10.1097/ICO.0b013e318199f73b.

PMID:
19724196
[PubMed - indexed for MEDLINE]
4.

Fibrinogen Alès: a homozygous case of dysfibrinogenemia (gamma-Asp(330)-->Val) characterized by a defective fibrin polymerization site "a".

Lounes KC, Soria C, Mirshahi SS, Desvignes P, Mirshahi M, Bertrand O, Bonnet P, Koopman J, Soria J.

Blood. 2000 Nov 15;96(10):3473-9.

PMID:
11071644
[PubMed - indexed for MEDLINE]
Free Article
5.

A hereditary dysfibrinogenemia: fibrinogen Awaji.

Matsuo T, Okuno S, Mukaida T, Ueshima S, Okada K, Matsuo O.

Haemostasis. 1987;17(1-2):89-97.

PMID:
3596361
[PubMed - indexed for MEDLINE]
6.

Acquired coagulation inhibitor delaying fibrinopeptide release.

Marciniak E, Greenwood MF.

Blood. 1979 Jan;53(1):81-92.

PMID:
758215
[PubMed - indexed for MEDLINE]
Free Article
7.

Fibrinogen Nový Jicín and Praha II: cases of hereditary Aalpha 16 Arg-->Cys and Aalpha 16 Arg-->His dysfibrinogenemia.

Kotlín R, Chytilová M, Suttnar J, Riedel T, Salaj P, Blatný J, Santrůcek J, Klener P, Dyr JE.

Thromb Res. 2007;121(1):75-84. Epub 2007 Apr 3.

PMID:
17408725
[PubMed - indexed for MEDLINE]
8.

Fibrinogen and dysfibrinogenemia.

Morse EE.

Ann Clin Lab Sci. 1980 Jul-Aug;10(4):351-5.

PMID:
7447388
[PubMed - indexed for MEDLINE]
9.

Fibrinogen Vicenza and Genova II: two new cases of congenital dysfibrinogenemia with isolated defect of fibrin monomer polymerization and inhibitory activity on normal coagulation.

Rodeghiero F, Castaman GC, Dal Belin Peruffo A, Dini E, Galletti A, Barone E, Gastaldi G.

Thromb Haemost. 1987 Jun 3;57(3):252-8.

PMID:
2958952
[PubMed - indexed for MEDLINE]
10.

[Inherited dysfibrinogenemia caused by Arg275His in the beta chain of fibrinogen].

Fang Y, Wang X, Qi H, Wu W, Ding Q, Dai J, Zhou R, Wang W, Xie S, Wang H.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2005 Apr;22(2):201-3. Chinese.

PMID:
15793786
[PubMed - indexed for MEDLINE]
11.

A novel Asp344Val substitution in the fibrinogen gamma chain (fibrinogen Caen) causes dysfibrinogenemia associated with thrombosis.

Robert-Ebadi H, Le Querrec A, de Moerloose P, Gandon-Laloum S, Borel Derlon A, Neerman-Arbez M.

Blood Coagul Fibrinolysis. 2008 Oct;19(7):697-9. doi: 10.1097/MBC.0b013e3282f544ee.

PMID:
18832913
[PubMed - indexed for MEDLINE]
12.

Fibrinogen Poissy II (gammaN361K): a novel dysfibrinogenemia associated with defective polymerization and peptide B release.

Mathonnet F, Guillon L, Detruit H, Mazmanian GM, Dreyfus M, Alvarez JC, Giudicelli Y, de Mazancourt P.

Blood Coagul Fibrinolysis. 2003 Apr;14(3):293-8.

PMID:
12695754
[PubMed - indexed for MEDLINE]
13.

Fibrinogen Magdeburg I: a novel variant of human fibrinogen with an amino acid exchange in the fibrinopeptide A (Aalpha 9, Leu-->Pro).

Meyer M, Kutscher G, Stürzebecher J, Riesener G, Lutze G.

Thromb Res. 2003 Jan 25;109(2-3):145-51.

PMID:
12706644
[PubMed - indexed for MEDLINE]
14.

[Increased thrombin time in a patient with multiple myeloma].

Bohler A, Redondo M, Lämmle B.

Ther Umsch. 1999 Sep;56(9):491-4. German.

PMID:
10517116
[PubMed - indexed for MEDLINE]
15.

Fibrinogen Baltimore IV: congenital dysfibrinogenemia with delayed fibrin monomer polymerization.

Ebert RF, Bell WR.

Thromb Res. 1985 Apr 15;38(2):121-8.

PMID:
4002201
[PubMed - indexed for MEDLINE]
16.

Fibrinogen Guarenas I: partial characterization of a new dysfibrinogenemia with an altered rate of fibrinopeptide release and an impaired polymerization.

Lundberg UG, Rodriguez S, Marchi R, Ruiz-Saez A, Arocha-Piñango CL.

Thromb Res. 1995 Apr 15;78(2):95-106.

PMID:
7482436
[PubMed - indexed for MEDLINE]
17.

Autoantibody to plasma fibrinopeptide A in a patient with a severe acquired haemorrhagic syndrome.

Gris JC, Schved JF, Branger B, Aguilar-Martinez P, Vécina F, Oulès R, Sarlat C, Fourcade J.

Blood Coagul Fibrinolysis. 1992 Oct;3(5):519-29.

PMID:
1450318
[PubMed - indexed for MEDLINE]
18.

The role of sialic acid in the dysfibrinogenemia associated with liver disease: distribution of sialic acid on the constituent chains.

Martinez J, MacDonald KA, Palascak JE.

Blood. 1983 Jun;61(6):1196-202.

PMID:
6839020
[PubMed - indexed for MEDLINE]
Free Article
19.

The molecular localization of the ability of certain monoclonal immunoglobulins to interfere with fibrin polymerization.

Wisløff F, Michaelsen TE, Kierulf P, Godal HC.

Thromb Res. 1985 Nov 15;40(4):473-82.

PMID:
4082120
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk